Follow
Silvia Bua
Title
Cited by
Cited by
Year
Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs–CAIs) for the treatment of rheumatoid arthritis
S Bua, L Di Cesare Mannelli, D Vullo, C Ghelardini, G Bartolucci, ...
Journal of medicinal chemistry 60 (3), 1159-1170, 2017
1292017
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC …
WM Eldehna, MF Abo-Ashour, A Nocentini, RS El-Haggar, S Bua, ...
European journal of medicinal chemistry 162, 147-160, 2019
902019
Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand/isoform matching and selectivity of action
A Bonardi, A Nocentini, S Bua, J Combs, C Lomelino, J Andring, ...
Journal of medicinal chemistry 63 (13), 7422-7444, 2020
862020
3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico …
MF Abo-Ashour, WM Eldehna, A Nocentini, A Bonardi, S Bua, HS Ibrahim, ...
European Journal of Medicinal Chemistry 184, 111768, 2019
742019
Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and …
WM Eldehna, GH Al-Ansary, S Bua, A Nocentini, P Gratteri, A Altoukhy, ...
European Journal of Medicinal Chemistry 127, 521-530, 2017
662017
Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases
A Nocentini, S Bua, CL Lomelino, R McKenna, M Menicatti, G Bartolucci, ...
ACS medicinal chemistry letters 8 (12), 1314-1319, 2017
652017
Structured optical materials controlled by light
S Nocentini, D Martella, C Parmeggiani, S Zanotto, DS Wiersma
Advanced Optical Materials 6 (15), 1800167, 2018
632018
Design and synthesis of novel 1, 3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors
N Lolak, S Akocak, S Bua, M Koca, CT Supuran
Bioorganic chemistry 77, 542-547, 2018
632018
Discovery of new ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors
N Lolak, S Akocak, S Bua, RKK Sanku, CT Supuran
Bioorganic & medicinal chemistry 27 (8), 1588-1594, 2019
582019
Discovery of β-adrenergic receptors blocker–carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy
A Nocentini, M Ceruso, S Bua, CL Lomelino, JT Andring, R McKenna, ...
Journal of Medicinal Chemistry 61 (12), 5380-5394, 2018
582018
Design and synthesis of novel benzenesulfonamide containing 1, 2, 3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors
R Kumar, L Vats, S Bua, CT Supuran, PK Sharma
European journal of medicinal chemistry 155, 545-551, 2018
562018
Discovery of novel 1, 3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors
S Akocak, N Lolak, S Bua, CT Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry 33 (1), 1575-1580, 2018
562018
Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as potent carbonic anhydrase IX inhibitors
N Lolak, S Akocak, S Bua, CT Supuran
Bioorganic Chemistry 82, 117-122, 2019
552019
Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
MF Abo-Ashour, WM Eldehna, A Nocentini, HS Ibrahim, S Bua, ...
European Journal of Medicinal Chemistry 157, 28-36, 2018
552018
Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies
MF Abo-Ashour, WM Eldehna, A Nocentini, HS Ibrahim, S Bua, ...
Bioorganic Chemistry 87, 794-802, 2019
522019
2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies …
N Chiaramonte, S Bua, M Ferraroni, A Nocentini, A Bonardi, G Bartolucci, ...
European Journal of Medicinal Chemistry 151, 363-375, 2018
492018
Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors
R Kumar, S Bua, S Ram, S Del Prete, C Capasso, CT Supuran, ...
Bioorganic & Medicinal Chemistry 25 (3), 1286-1293, 2017
492017
Synthesis and biological evaluation of benzenesulphonamide-bearing 1, 4, 5-trisubstituted-1, 2, 3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory …
R Kumar, V Sharma, S Bua, CT Supuran, PK Sharma
Journal of Enzyme Inhibition and Medicinal Chemistry 32 (1), 1187-1194, 2017
462017
Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors
MA Said, WM Eldehna, A Nocentini, A Bonardi, SH Fahim, S Bua, ...
European Journal of Medicinal Chemistry 185, 111843, 2020
452020
Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII …
HI Gul, C Yamali, M Bulbuller, PB Kirmizibayrak, M Gul, A Angeli, S Bua, ...
Bioorganic chemistry 78, 290-297, 2018
452018
The system can't perform the operation now. Try again later.
Articles 1–20